Search - tctmd.com

Displaying 21 - 40 of 91

Sort: Relevancy | Date

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

Presentation TCT 2021

TCT 633: A Clinical Case of Performing Optical CoherenceTomography of the Renal Arteries During Carboxyangiography to Assess the Safety of the Renal Denervation Procedure in a Patient With Uncontrolled Hypertension and Iodine-Containing Contrast Allergy.

Presenter: Mikhail Tarasov

November 04, 2021

Age Not the Only Explanation for Sex Gap in PCI Care, Outcomes

News Daily News

Age Not the Only Explanation for Sex Gap in PCI Care, Outcomes

November 03, 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

News Opinion Editor's Corner TCT 2021

In-Person and Online: TCT to Showcase Imaging, Valves, DCBs, and More

November 01, 2021

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

News Daily News

Only a Minority of Stable PCI Patients Meet ISCHEMIA Criteria, Study Contends

November 01, 2021

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

News Daily News

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

October 26, 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

October 22, 2021

Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Presentation TCT 2021

Invasive versus Medical Management In Patients with Chronic Kidney Disease and Non-ST-Elevation Myocardial Infarction

Presenter: Ankur Kalra

October 20, 2021

Half-Dose DOAC May Be a Good Post-Watchman Option

News Daily News

Half-Dose DOAC May Be a Good Post-Watchman Option

October 14, 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

October 08, 2021

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

News Daily News

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

September 21, 2021

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

News Daily News

Valve-in-Valve TAVI Bests Redo SAVR in Short Term

Michael O'Riordan

September 20, 2021

Renal Denervation a Third Option for Hypertension, European Experts Say

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

September 17, 2021

PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves

News Conference News ESC 2021

PET Imaging Detects Degeneration After TAVI as Well as Surgical, Native Valves

Yael L. Maxwell

September 02, 2021

Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival

News Conference News ESC 2021

Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival

September 01, 2021

STEP Trial Supports Lower BP Goal in Older Patients With Hypertension

News Conference News ESC 2021

STEP Trial Supports Lower BP Goal in Older Patients With Hypertension

August 30, 2021

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

News Conference News ESC 2021

Finerenone Reduces CV Outcomes in Patients With Early CKD, Diabetes: FIGARO-DKD

Michael O'Riordan

August 28, 2021

EMPEROR-Preserved: Empagliflozin Improves Outcomes in HFpEF

News Conference News ESC 2021

EMPEROR-Preserved: Empagliflozin Improves Outcomes in HFpEF

August 27, 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

News Conference News ESC 2021

Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5

August 24, 2021

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

News Daily News

Multivessel PCI May Be Less Suitable for Elderly STEMI Patients: NCDR Data

August 20, 2021

FDA Green-lights Empagliflozin for HF With Reduced Ejection Fraction

News Daily News

FDA Green-lights Empagliflozin for HF With Reduced Ejection Fraction

Michael O'Riordan

August 19, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.